Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$633M |
| 2 |
Willis Towers Watson
WTW
|
+$528M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$525M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$431M |
| 5 |
AGN
Allergan plc
AGN
|
+$384M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.17B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$352M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$339M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.73% |
| 2 | Healthcare | 5.73% |
| 3 | Financials | 5.39% |
| 4 | Consumer Discretionary | 4.7% |
| 5 | Communication Services | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VSLR
5551
DELISTED
VIVINT SOLAR, INC.
VSLR
| $70K | ﹤0.01% |
16,067
+5,958
| +59% | +$50.6K |
|
|
CHK
5552
PUT
DELISTED
Chesapeake Energy Corporation
CHK
| $70K | ﹤0.01% |
2,038
-4,556
| -69% | -$400K |
|
5553
CALL
ANI Pharmaceuticals
ANIP
$1.83B
| $69K | ﹤0.01% |
1,700
| – | – |
|
5554
Asure Software
ASUR
$240M
| $69K | ﹤0.01% |
11,575
+2,479
| +27% | +$19.2K |
|
5555
WisdomTree US SmallCap Dividend Fund
DES
$2.19B
| $69K | ﹤0.01% |
3,830
-2,185
| -36% | -$54K |
|
5556
CALL
Dine Brands
DIN
$457M
| $69K | ﹤0.01% |
2,400
-10,300
| -81% | -$747K |
|
|
KIO
5557
KKR Income Opportunities Fund
KIO
$454M
| $69K | ﹤0.01% |
6,513
+4,513
| +226% | +$65.7K |
|
5558
CALL
Lamb Weston
LW
$7.36B
| $69K | ﹤0.01% |
1,200
+100
| +9% | +$8.22K |
|
5559
PUT
Ryanair
RYAAY
$31.2B
| $69K | ﹤0.01% |
3,250
+2,750
| +550% | +$86.7K |
|
|
TVRD
5560
PUT
Tvardi Therapeutics
TVRD
$19.7M
| $69K | ﹤0.01% |
144
-520
| -78% | -$283K |
|
|
SGEN
5561
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
| $69K | ﹤0.01% |
600
-13,100
| -96% | -$1.45M |
|
|
GLOG
5562
DELISTED
GASLOG LTD
GLOG
| $69K | ﹤0.01% |
18,893
-229,668
| -92% | -$1.4M |
|
|
FBM
5563
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $69K | ﹤0.01% |
6,714
-4,124
| -38% | -$67K |
|
5564
Byline Bancorp
BY
$1.78B
| $68K | ﹤0.01% |
6,578
+1,850
| +39% | +$31.3K |
|
|
CCRD
5565
DELISTED
CoreCard
CCRD
| $68K | ﹤0.01% |
1,994
+508
| +34% | +$19K |
|
5566
Caesarstone
CSTE
$71.6M
| $68K | ﹤0.01% |
6,451
+1,905
| +42% | +$23.2K |
|
5567
Cytosorbents Corp
CTSO
$22M
| $68K | ﹤0.01% |
8,819
+2,531
| +40% | +$12.8K |
|
5568
First Trust Germany AlphaDEX Fund
FGM
$99.1M
| $68K | ﹤0.01% |
2,160
-322
| -13% | -$12.8K |
|
5569
Intercorp Financial Services
IFS
$6.5B
| $68K | ﹤0.01% |
2,437
| – | – |
|
5570
PUT
Ingredion
INGR
$6.33B
| $68K | ﹤0.01% |
900
-2,400
| -73% | -$206K |
|
5571
Lifecore Biomedical
LFCR
$164M
| $68K | ﹤0.01% |
7,842
+2,563
| +49% | +$26.7K |
|
5572
Nuveen California Quality Municipal Income Fund
NAC
$1.84B
| $68K | ﹤0.01% |
4,992
-6,419
| -56% | -$94.4K |
|
5573
PUT
Intellia Therapeutics
NTLA
$1.55B
| $68K | ﹤0.01% |
5,600
-20,200
| -78% | -$272K |
|
5574
PUT
Precigen
PGEN
$2.12B
| $68K | ﹤0.01% |
20,100
-16,400
| -45% | -$70.8K |
|
5575
Red River Bancshares
RRBI
$649M
| $68K | ﹤0.01% |
1,838
+825
| +81% | +$41.3K |
|
Similar funds
Citigroup's Q1 2020 Portfolio in Review
As of Q1 2020, Citigroup held 8,003 positions worth $111B, down 20% from $138B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Citigroup's Q1 2020 filing shows 244 new, 3,316 increased, 3,513 reduced and 342 closed positions. Its largest new stake was Direxion Flight to Safety Strategy ETF: 100,000 shares worth $5.01M. The largest sale was Invesco QQQ Trust, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 6.7% of assets, up from 6.7% a quarter earlier, followed by Healthcare and Financials.
- Citigroup's largest Q1 2020 buy was Direxion Flight to Safety Strategy ETF: 100,000 shares worth $5.01M.
- Citigroup added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q1 2020, an estimated $633M increase.
- Citigroup's biggest Q1 2020 reduction was Invesco QQQ Trust, cutting an estimated $1.17B.
- Citigroup fully exited Zayo Group Holdings, Inc. in Q1 2020, selling an estimated $327M.
- Citigroup's ten largest holdings make up 24% of its $111B portfolio in Q1 2020.
- Citigroup opened 244 new positions and closed 342 in Q1 2020.
- Citigroup's portfolio value fell 20% quarter-over-quarter to $111B.
Based on Citigroup's 13F filing for Q1 2020, filed 12 May 2020.